Journal of Cardiovascular and Pulmonary Diseases was founded in February 1982 by Dr. Wu Yingkai, the father of thoracic and cardiovascular surgery in China, and Dr. Weng Xinzhi, an expert in pulmonary disease. This journal is a professional academic bimonthly issue for the prevention, health care, scientific research, and international academic exchange of cardiovascular and pulmonary diseases. The Journal focuses on basic research, clinical techniques, and developments in cardiovascular and pulmonary diseases. The publication includes sections for epidemiology, clinical work, basic research, smoking and health case reports, clinical pathology discussion, and lectures, as well as columns for basic science, reviews, and academic developments and activities, among other topics. The Journal was included in American Chemical Abstracts in 2006 and was listed as one of the “Chinese scientific and technical papers and citations” periodicals by the National Ministry of Science and Technology. It was selected in the Chinese journals formation in 2001, and is included in the Chinese Core Journals (selection) and SinoMed databases.

（图1）

  图（2）

Yujie Zhou, Professor

chief physician, professor, doctoral supervisor, competent person of postdoctoral station, national major clinical discipline leader, secretary general of Chinese Society of Cardiology, deputy director member of Committee of Cardio-cerebral-vascular Disease, Gerontology Society of China, director member of Expert Committee of China Society for the Promotion of International Exchange, deputy director member of Committee of Cardiovascular Diseases of China Elder Health Care Association, deputy director member of Beijing Commission of Chronic Disease Management, deputy director member of Beijing Cardiovascular Working Commission of Chinese Medical Association, director member of Grassroots Working Committee of Chinese Medical Doctor Association, director member of Cardiovascular Commission of Chinese Medical Doctor Association, and diagnosis expert of Central Healthcare Commission, president of Journal of Heart, Lung and Blood Vessel Diseases, editorial board member of Chinese Medical Journal and other medical publications, good at sophisticated, highly difficult and high-risk percutaneous coronary interventional therapy and emergency treatment of critical cardiovascular diseases, winner of Leading Talent in Beijing Health System, Outstanding Health Science and Technology Talent, New Century Ten, Hundred and Thousand Outstanding Talent and Young and Middle-Aged Expert with Outstanding Contributions, concurrently acting as senior members of FACC, FHRS, FSCAI and FESC of International Society of Cardiovascular Diseases.

Research Interests: Clinical treatment and basic research of cardiovascular diseases.

Principal Investigator

· “Effect of kruppel-like factor 2 transcription factor in endothelial dysfunction induced by rapamycin”. Funded by the National Natural Science Foundation of China. Support period: 01/2010–12/2012.

· “Effect and mechanism of endoplasmic reticulum stress induced by angiotensin II on contrast-induced renal tubular cell apoptosis”. Funded by the National Natural Science Foundation of China. Support period: 01/2013–12/2016.

Participating Investigator

· Directed sub-project “Study on the technique system of early diagnosis and treatment of coronary heart disease”. Funded by the Eleventh Five-Year National Science and Technology Support Program.

SCI papers published in the past five years:

1. Gao F, Zhou YJ, Wang ZJ, Yang SW, Nie B, Liu XL, Jia de A, Yan ZX. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation. Int J Cardiol. 2011 (148):96-101.(IF 7.078)

2. Liu W, Zhou YJ*, Liu YY, Shi DM.Is this spontaneous coronary intramural hematoma or fibrotic plaque?: an inconsistent finding between optical coherent tomography and intravascular ultrasound. JACC Cardiovascular Intervention. 2013 Sep;6(9):983-4.(IF 6.55)

3. Yang SW, Zhou YJ*, Tian XF, Pan GZ, Liu YY, Zhang J, Guo ZF, Chen SY, Gao ST, Du J, Jia DA, Fang Z, Hu B, Han HY, Gao F, Hu DY, Xu YY; Beijing Heart and Metabolism Survey Study Group.Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease. Mayo Clin Proc.2013 Sep;88(9):930-41.(IF 5.79)

Address：E-mail：azzyj12@163.com Tel：010-64456489

Wenbin Li, Professor, Chief Cardiac Surgeon, Tutor of Doctors, Vice-Director of Heart, Lung and Blood Vessel Diseases

Research Interests: Clinical and basic cardiac surgery; Tissue engineering.

Principal Investigator

· “Pulmonary autograft transplantation in the treatment of mitral valve disease”. Funded by the National Natural Foundation Project (30371412). Support period: 01/2004–12/2006.

· “The establishment of parasitic ventricular theory”. Funded by the National Natural Foundation Project (81070077). Support period: 01/2011–12/2013.

· “The establishment of parasitic ventricular theory”. Funded by the Beijing Natural Foundation Innovation Fund (7083106). Support period: 01/2008–06/2009.

· Beijing Health Personnel High Levels Fund. Support period: 06/2010–07/2013.

Participating Investigator

· Directed sub-project “The new idea of resolving pulmonary valve conduit tissue biomechanical properties and immunogenicity of contradiction”. (81270217). Support period: 01/2013–12/2016.

In 2005, Professor Li was elected to the Beijing City Health “100” People Plan, “Ten, Hundred, Thousand Project”.

SCI papers published in the past five years:

1. Wan J, Li W, Zhou Z, et al.Primary cardiac paraganglioma with intratumoral coronary artery aneurysm.Ann Thorac Surg，2014，97(3):e75-77.

2. Liu XM, Wu H, Zhang WK, Xu ZW, Xu XF, Li WB, Meng X, Chen BT, Zhou QW, Zhou ZF. Long-term results of surgical treatment of aortic and mitral regurgitation with enlarged left ventricle. Int J Clin Exp Med 2014;7(3):709-713

3. Xu XF, Guo HP, Ren XJ, Gong D, Ma JH, Wang AP, Shi HF, Xin Y, Wu Y, Li WB.Effect of carbodiimide cross-linking of decellularized porcine pulmonary artery valvular leaflets. Int J Clin Exp Med 2014,7(3):649-656,

4. Li W, Li L, Xu X, An Z, Chao Q, Zhou Z, Hua G, Zhou H, Liu A, Wan Z. Aortic Root Wrapped Procedure for Treating Aortic Root Sinus Aneurysm.Surg Innov. 2014 Oct 27. pii: 1553350614554234. [Epub ahead of print].

5. Xu Z, Li W, Xu X, Zhou Z, Song S, Ma J, Zhang J. Long-Term Follow-Up with Ross Procedure at a Single Institution in China. Thorac Cardiovasc Surg. 2014; 62(3):216-221.

6. Xu XF, Guo HP, Gong D, Ma JH, Xu ZW, Wan JY, Wang ZG, Zhou ZF, Li WB, Xin Y. Decellularized porcine pulmonary arteries cross-linked by carbodiimide.Int J Clin Exp Med. 2013;6(7):524-531.

7. Xu XF, Xin Y, Zhang Y, Huang YM, Li WB, Li N, Lin Z, Zhou YJ, Zhang ZG. Expression of lymphocyte coding genes in peripheral blood and lymphocyte infiltration in cardiac tissues influenced by cyclosporin A in heterotopic heart transplantation model in rats. Transpl Immunol. 2013;29(1-4):82-87.

8. Xu XF, Wang ZH, An GY, Guo HP, Wang S, Pei JF, Qin EM, Ren XJ, Xu ZW, Gong D, Li WB. A novel surgical procedure: scaffold-pulmonary autograft transplantation. Int J Clin Exp Med. 2013;6(8):662-666.

9. Wu H, Xu ZW, Liu XM, Gong D, Wan JY, Xu XF, Zhou ZF, Li WB. An in vivo model of in situ implantation using pulmonary valved conduit in large animals under off-pump condition Chin Med J (Engl). 2013;126(23):4540-4544.

10. Xu XF, Xin Y, Zhang Y, Huang YM, Gu Y, Li N, Li WB, Zhou YJ, Zhang ZG. Expressional time phase of leukocyte molecules induced by allogenic cardiac antigen and cyclosporin A in rats' in vitro model.Int J Clin Exp Med. 2013;6(5):404-412.

Address：E-mail：liwenbin65@vip.sina.com Tel：13370103053

Shang Dong Xu, Associate Professor

Research Interests: Adult cardiac surgery; Aortic surgery; Aortic endovascular repair.

Principal Investigator

· “Mechanism of multiple layers aortic repair system in maintaining of branch flow”. Funded by the National Natural Science Foundation of China. Support period: 01/2013–12/2016. (Second responsible person.)

· “Standard treatment and key techniques of aortic dissection”. Funded by the Special Scientific Research Fund (National Health and Family Planning Commission of People’s Republic of China). Support period: 01/2014–12/2016. (Responsible person of a sub-topic.)

SCI papers published in the past five years:

1. Huang FJ, Wu Q, Ren CW, et al. Cannulation of the innominate artery with a side graft in arch surgery. Ann Thorac Surg. 2010. 89(3): 800-803.

2. Xu SD, Huang FJ, Yang JF, et al. Early and midterm results of thoracic endovascular aortic repair of chronic type B aortic dissection. J ThoracCardiovasc Surg. 2010. 139(6): 1548-53.

3. Ren C, Xu S, Lai Y, Sun L. Nonoperative management of an iatrogenic ascending aortic dissection. J Card Surg. 2014 Sep;29(5):667-9.

Address：E-mail：xushangdong@126.com Tel：010-64456496